Related Experiment Videos
Operation for congenital megacolon in a hemophilic patient
Abstract:
A 13-year-old boy with congenital megacolon and hemophilia A underwent a Duhamel operation and closure of colostomy with administration of large amounts of antihemophilic factor. The intraoperative level of this factor was 80%, and the postoperative level was maintained at about 70% during the first week and at 30% during the second week. There was no bleeding tendency during or after surgery.
Insights
This study details a successful Duhamel operation for a boy with congenital megacolon and hemophilia A. Effective management of antihemophilic factor levels prevented bleeding complications post-surgery.
Area of Science:
- Pediatric Surgery
- Hematology
Background:
- Congenital megacolon (Hirschsprung's disease) requires surgical intervention.
- Hemophilia A poses significant bleeding risks during and after surgery.
Observation:
- A 13-year-old male patient with both conditions underwent a Duhamel operation and colostomy closure.
- Large volumes of antihemophilic factor were administered perioperatively.
Findings:
- Intraoperative antihemophilic factor levels reached 80%.
- Postoperative levels were maintained at 70% (week 1) and 30% (week 2).
- No intraoperative or postoperative bleeding was observed.
Implications:
- Aggressive factor replacement is crucial for managing hemophilia A patients undergoing major surgery.
- This case demonstrates the feasibility of complex surgical procedures in patients with bleeding disorders.
- Optimized factor management can lead to favorable surgical outcomes in pediatric patients with congenital megacolon and hemophilia A.